Garry Weems

Garry Weems has a strong background in clinical science, with experience in various leadership roles at companies such as Abcuro, Inc, Avalo Therapeutics, Lycera, Arbor Pharmaceuticals, Allos Therapeutics, and MGI Pharma. Garry holds a PharmD from the University of Minnesota and completed their education at Bethel University.